ShmuelShohamMD

Infectious Disease • Baltimore, MD

Transplant/Immunocompromised States

Associate Professor of Medicine, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Shoham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shoham's full profile

Already have an account?

Office
600 N Wolfe St
1830 Bldg RM 450
Baltimore, MD 21287
Phone+1 410-614-6431

Fax+1 410-614-0714

Education & Training

Boston University Medical CenterFellowship, Infectious Disease, 1998 - 2001
Boston University Medical CenterResidency, Internal Medicine, 1994 - 1997
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994

Certifications & Licensure

MD State Medical License 2010 - 2025
DC State Medical License 2001 - 2024
FL State Medical License 2017 - 2019
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza Start of enrollment: 2010 Dec 01
Completed
Phase 2
The Johns Hopkins Transplant Infectious Diseases Prospective Cohort Study Start of enrollment: 2011 Jun 01
Completed
Convalescent Plasma to Stem Coronavirus (CSSC-001) Start of enrollment: 2020 Jun 10
Completed
Phase 2

Publications & Presentations

PubMed

47 citations
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 20...
Jeffrey D. Jenks, Danila Seidel, Oliver A. Cornely, Sharon C.-A. Chen, S. J. van Hal
Clinical Microbiology and Infection. 2020-06-01
555 citations
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various...
Samira M. Garonzik, Jian Li, Visanu Thamlikitkul, David L. Paterson, Shmuel Shoham
Antimicrobial Agents and Chemotherapy. 2011-07-01
123 citations
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
Sabra L. Klein, Andrew Pekosz, Han-Sol Park, Rebecca L. Ursin, Janna R. Shapiro
Medrxiv. 2020-06-28

Journal Articles

Graded Isavuconazole Introduction in a Patient with Voriconazole Allergy
Shmuel Shoham, MD, Transplant Infectious Disease

Press Mentions

Study Shows Convalescent Plasma Works for Immune-Compromised Covid-19 Patients, but It Can Be Hard to FindJanuary 12th, 2023
COVID Convalescent Plasma Finds a Therapeutic RoleJune 19th, 2022
Why Catching COVID-19 to ‘Get It over With’ Is a Terrible IdeaJanuary 23rd, 2022
Join now to see all

Other Languages

Hebrew

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/shmuel-shoham